Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene t... Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York. Mostrar más
| Período † | Variación(Ptos) | Variación % | Apertura | Precio Máximo | Precio Mínimo | Avg. Vol. diario | Precio Promedio Ponderado | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.05 | 35.7142857143 | 2.94 | 4.56 | 2.47 | 2057778 | 4.0405125 | CS |
| 4 | 0.68 | 20.5438066465 | 3.31 | 4.56 | 2.32 | 963116 | 3.44283265 | CS |
| 12 | -2.72 | -40.5365126677 | 6.71 | 7.66 | 2.32 | 502999 | 3.95682673 | CS |
| 26 | -5.05 | -55.8628318584 | 9.04 | 11.72 | 2.32 | 433233 | 5.88619209 | CS |
| 52 | -10.7 | -72.838665759 | 14.69 | 19.5 | 2.32 | 337551 | 8.62166088 | CS |
| 156 | -5.51 | -58 | 9.5 | 22.33 | 2.32 | 278128 | 9.29574863 | CS |
| 260 | -5.51 | -58 | 9.5 | 22.33 | 2.32 | 278128 | 9.29574863 | CS |
Parece que no se ha autenticado. Haga click al botón de abajo para iniciar la sesión y ver los símbolos recientemente consultados.
Soporte: (55) 4170 8128 | soporte@advfn.mx
Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones
Hot Features
Premium
